The American Society for Gastrointestinal Endoscopy (ASGE) recently opened two guidance documents for public comment. A clinical practice guideline update for Role of Remimazolam in Gastrointestinal Endoscopy and a guidance document regarding real-time computer-aided detection (CADe) of colorectal neoplasia during colonoscopy are now both open to public comment. Prospective reviewers will need to complete a conflict-of-interest disclosure and a non-disclosure agreement prior to viewing the draft documents.
Click here to view the clinical practice guideline update, Role of Remimazolam in Gastrointestinal Endoscopy.
Click here to view the guidance document, ASGE Guidance on Role of Real-Time Computer-Aided Detection (CADe) of Colorectal Neoplasia During Colonoscopy.
The public comment window for the clinical practice update runs through June 29, 2026. The public comment window for the guidance document runs through July 5, 2026.
Check out our other gastroenterology-related content and sign up for alerts to keep up with the latest clinical guidelines and guideline updates.